title: Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy.
authors.forename: Timm H
authors.initials: TH
authors.lastname: Westhoff
authors.forename: Friederike
authors.initials: F
authors.lastname: Jochimsen
authors.forename: Alexander
authors.initials: A
authors.lastname: Schmittel
authors.forename: Marina
authors.initials: M
authors.lastname: Stoffler-Meilicke
authors.forename: Jurgen H
authors.initials: JH
authors.lastname: Schafer
authors.forename: Walter
authors.initials: W
authors.lastname: Zidek
authors.forename: Wolfram H
authors.initials: WH
authors.lastname: Gerlich
authors.forename: Eckhard
authors.initials: E
authors.lastname: Thiel
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D006509:Hepatitis B / Q000209:etiology*; D006515:Hepatitis B virus / Q000235:genetics*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D009154:Mutation; D012008:Recurrence; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab